Significant Ownership of Clearline Capital LP
- Signature - Title
- Marc Majzner - Limited Partner
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Clearline Capital LP.
Follow Filing Activity
Follow Clearline Capital LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Clearline Capital LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Common Stock, par value $0.01 per share | 6.7% | $18,108,154 | +$3,733,614 | 12,235,239 | +26% | Clearline Capital LP | 31 Dec 2025 |
| XPER | Xperi Inc. | Common Stock (par value $0.001 per share) | 6.4% | $17,787,867 | 2,949,895 | Clearline Capital LP | 31 Dec 2025 | ||
| TXMD | TherapeuticsMD, Inc. | Common Stock, par value $0.001 per share | 5.5% | $705,096 | 635,222 | Clearline Capital LP | 31 Dec 2024 | ||
| MX | MAGNACHIP SEMICONDUCTOR Corp | Common Stock, par value $0.01 per share | 4.1% | $3,725,642 | -$1,119,807 | 1,461,036 | -23% | Clearline Capital LP | 31 Dec 2025 |
Schedules 13D/G Reported by Clearline Capital LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.